Rheumatology Academy

Where education meets excellence.
The latest rheumatology CME
& clinical updates you need.

Where education meets excellence.
The latest rheumatology CME & clinical updates you need.

Defining the Challenge in Complex Cases of Psoriatic Arthritis
Defining the Challenge in Complex Cases of Psoriatic Arthritis
Living Rheum
Defining the Challenge in Complex Cases of Psoriatic Arthritis
- Laura Coates, MBChB, MRCP, PhD
Decoding the Data: Early Biologic Use and Psoriatic Arthritis
Decoding the Data: Early Biologic Use and Psoriatic Arthritis
Living Rheum
Decoding the Data: Early Biologic Use and Psoriatic Arthritis
- Laura Coates, MBChB, MRCP, PhD
Navigating the Modern PsA Treatment Landscape
Navigating the Modern PsA Treatment Landscape
Living Rheum
Navigating the Modern PsA Treatment Landscape
Rethinking SLE Treatment: Recent Approvals, Novel Targets, and What’s Next
Rethinking SLE Treatment: Recent Approvals, Novel Targets, and What’s Next
Living Rheum
Rethinking SLE Treatment: Recent Approvals, Novel Targets, and What’s Next
- Steve Jackson, PharmD
- Marc Scherlinger, MD, PhD
Understanding Preload Deficiency in SLE: A New Look at Fatigue and Exercise Intolerance
Understanding Preload Deficiency in SLE: A New Look at Fatigue and Exercise Intolerance
Living Rheum
Understanding Preload Deficiency in SLE: A New Look at Fatigue and Exercise Intolerance
- Ryan Quigley
- Luigi Adamo, MD, PhD
- Andrea Fava, MD
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Living Rheum
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
- Ryan Quigley
Delaying Rheumatoid Arthritis with Abatacept: ARIAA Trial Findings
Delaying Rheumatoid Arthritis with Abatacept: ARIAA Trial Findings
Living Rheum
Delaying Rheumatoid Arthritis with Abatacept: ARIAA Trial Findings
Improving Risk Stratification in Lupus Nephritis: The Role of Urinary Biomarkers
Improving Risk Stratification in Lupus Nephritis: The Role of Urinary Biomarkers
Living Rheum
Improving Risk Stratification in Lupus Nephritis: The Role of Urinary Biomarkers